![Post thumbnail Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches features and perspectives](https://r5fb28.n3cdn1.secureserver.net/wp-content/uploads/2019/11/rare-diseases_700x425.jpg?time=1722078971)
Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives
There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening diseases for which there are no adequate licensed therapies.
Emmanuelle Voisin, David Uguen
2014 – Orphanet Journal of Rare Diseases